本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

26.77
-0.1700-0.63%
盤前26.62-0.1500-0.56%06:31 EDT
成交量:44.19萬
成交額:1,183.32萬
市值:19.53億
市盈率:-113.60
高:27.00
開:27.00
低:26.39
收:26.94
資料載入中...
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/23

摘牌通告

Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend]
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/02

SEC問詢函

Form CORRESP - Correspondence
2024/06/28

摘牌通告

Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/25

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/05

重要事件披露

Form 8-K - Current report
2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]